CORPORATES Alembic Pharmaceuticals receives USFDA approval for Fingolimod capsules; targets $145 million market 12:05 PM IST
CORPORATES Alembic Pharma reports first U.S. prescription sale of Pivya after commercial launch Mar 6, 2026
CORPORATES Alembic Pharma secures USFDA final approval for Lamotrigine Orally Disintegrating Tablets Feb 26, 2026
Alembic Pharma acquires UK-based Utility Therapeutics for $12 million to expand US presence Jul 3, 2025
Alembic Pharma share jump 11% after company gets US FDA approval for Doxorubicin Hydrochloride Injection Jun 30, 2025
Alembic Pharma Q2 FY25 Results: Revenue jumps 3.3% YoY to ₹1,647.98 crore, net profit jumps 12.2% YoY Nov 7, 2024
Alembic Pharmaceuticals receives USFDA final approval for Lamotrigine Extended-Release Tablets Oct 3, 2024
Stocks To Watch Today: Sun Pharma, Alembic Pharma, BEL, Crompton Greaves, and Campus Activewear Mar 27, 2023